Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Journal of Applied Biomedicine|June 24, 2024
The impact of obesity, age, and gender on plasmatic levels of selected glycoprotein biomarkers and miRNA-499 in OSA patientsTomas Kostlivy, Martin Pesta, Jindra Windrichova, et al.
Cancer Genetics and Cytogenetics|July 13, 2010
Relevance of miR-21 and miR-143 expression in tissue samples of colorectal carcinoma and its liver metastasesVlastimil Kulda, Martin Pesta, Ondrej Topolcan, et al.
International Journal of Oncology|April 16, 2016
Tissue microRNAs as predictive markers for gastric cancer patients undergoing palliative chemotherapyDavid Smid, Vlastimil Kulda, Kristyna Srbecka, et al.
Anticancer Research|May 29, 2017
Serum Levels of IGF-1 and IGFBP-3 in Relation to Clinical and Pathobiological Aspects of Head and Neck Squamous Cell CarcinomasDavid Kalfert, Marie Ludvikova, Ondrej Topolcan, et al.
International Journal of Cancer|August 12, 2018
Prodrug suicide gene therapy for cancer targeted intracellular by mesenchymal stem cell exosomesUrsula Altanerova, Jana Jakubechova, Katarina Benejova, et al.
Pathology, Research and Practice|May 2, 2024
BRAF mutation, selected miRNAs and genes expression in primary papillary thyroid carcinomas and local lymph node metastasesDavid Kalfert, Marie Ludvikova, Martin Pesta, et al.
Anticancer Research|April 13, 2016
Searching for New Biomarkers and the Use of Multivariate Analysis in Gastric Cancer DiagnosticsRadek Kucera, David Smid, Ondrej Topolcan, et al.
Anticancer Research|September 16, 2016
Prognostic Significance of TMPRSS2-ERG Fusion Gene in Prostate CancerVlastimil Kulda, Ondrej Topolcan, Radek Kucera, et al.
In Vivo (Athens, Greece)|June 27, 2024
Prognostic Value of Tumor Tissue Up-regulated microRNAs in Clear Cell Renal Cell Carcinoma (ccRCC)Martin Pesta, Ivan Travnicek, Vlastimil Kulda, et al.
Pageof 6